Table of Contents Author Guidelines Submit a Manuscript
Corrigendum

A corrigendum for this article has been published. To view the corrigendum, please click here.

BioMed Research International
Volume 2015 (2015), Article ID 793257, 31 pages
http://dx.doi.org/10.1155/2015/793257
Review Article

Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses

Department of Molecular Virology, Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA

Received 13 March 2015; Accepted 14 June 2015

Academic Editor: Kevin M. Coombs

Copyright © 2015 Joseph W. Golden et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. G. Meerburg, G. R. Singleton, and A. Kijlstra, “Rodent-borne diseases and their risks for public health,” Critical Reviews in Microbiology, vol. 35, no. 3, pp. 221–270, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Goeijenbier, J. Wagenaar, M. Goris et al., “Rodent-borne hemorrhagic fevers: under-recognized, widely spread and preventable-epidemiology, diagnostics and treatment,” Critical Reviews in Microbiology, vol. 39, no. 1, pp. 26–42, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. M. R. Hilleman, “Overview: cause and prevention in biowarfare and bioterrorism,” Vaccine, vol. 20, no. 25-26, pp. 3055–3067, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Paessler and D. H. Walker, “Pathogenesis of the viral hemorrhagic fevers,” Annual Review of Pathology: Mechanisms of Disease, vol. 8, pp. 411–440, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. D. R. Smith, M. R. Holbrook, and B. B. Gowen, “Animal models of viral hemorrhagic fever,” Antiviral Research, vol. 112, pp. 59–79, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. C. J. Peters, P. B. Jahrling, C. T. Liu, R. H. Kenyon, K. T. McKee Jr., and J. G. B. Oro, “Experimental studies of arenaviral hemorrhagic fevers,” Current Topics in Microbiology and Immunology, vol. 134, pp. 5–68, 1987. View at Google Scholar · View at Scopus
  7. M.-L. Moraz and S. Kunz, “Pathogenesis of arenavirus hemorrhagic fevers,” Expert Review of Anti-Infective Therapy, vol. 9, no. 1, pp. 49–59, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. M. J. Buchmeier, J. C. De la Torre, and C. J. Peters, “Arenaviridae: the viruses and their replication,” in Fields Virology, D. M. Knipe and P. M. Howley, Eds., vol. 2, pp. 1283–1303, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 5th edition, 2013. View at Google Scholar
  9. C. Armstrong and R. D. Lillie, “Experimental lymphocytic chriomeningitis of monkeys and mice produced by a virus encountered in studies of the 1993 St. Louis encephalitis epidemic,” Public Health Reports (1896-1970), vol. 49, no. 35, pp. 1019–1027, 1934. View at Publisher · View at Google Scholar
  10. J. E. Smadel, R. H. Green, R. M. Paltauf, and T. A. Gonzales, “Lymphocytic choriomeningitis: two human fatalities following an unusual febrile illness,” Experimental Biology and Medicine, vol. 49, no. 4, pp. 683–686, 1942. View at Publisher · View at Google Scholar
  11. J. B. McCormick and S. P. Fisher-Hoch, “Lassa fever,” Current Topics in Microbiology and Immunology, vol. 262, pp. 75–109, 2002. View at Google Scholar · View at Scopus
  12. D. Safronetz, N. Sogoba, J. E. Lopez et al., “Geographic distribution and genetic characterization of Lassa virus in sub-Saharan Mali,” PLoS Neglected Tropical Diseases, vol. 7, no. 12, Article ID e2582, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. M. D. Bowen, C. J. Peters, and S. T. Nichol, “The phylogeny of New World (Tacaribe complex) arenaviruses,” Virology, vol. 219, no. 1, pp. 285–290, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. R. N. Charrel and X. de Lamballerie, “Arenaviruses other than Lassa virus,” Antiviral Research, vol. 57, no. 1-2, pp. 89–100, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. J. T. Paweska, N. H. Sewlall, T. G. Ksiazek et al., “Nosocomial outbreak of novel arenavirus infection, southern Africa,” Emerging Infectious Diseases, vol. 15, no. 10, pp. 1598–1602, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Delgado, B. R. Erickson, R. Agudo et al., “Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia,” PLoS Pathogens, vol. 4, no. 4, Article ID e1000047, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. Centers for Disease Control and Prevention (CDC), “Fatal illnesses associated with a New World arenavirus—California, 1999-2000,” The Journal of the American Medical Association, vol. 284, pp. 1237–1238, 2000. View at Google Scholar
  18. A. S. Parodi, H. R. Rugiero, D. J. Greenway et al., “Isolation of the Junin virus (epidemic hemorrhagic fever) from the mites of the epidemic area (Echinolaelaps echidninus, Barlese),” Prensa Médica Argentina, vol. 46, pp. 2242–2244, 1959. View at Google Scholar · View at Scopus
  19. K. M. Johnson, R. B. Mackenzie, P. A. Webb, and M. L. Kuns, “Chronic infection of rodents by Machupo virus,” Science, vol. 150, no. 3703, pp. 1618–1619, 1965. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Salazar-Bravo, L. A. Ruedas, and T. L. Yates, “Mammalian reservoirs of arenaviruses,” Current Topics in Microbiology and Immunology, vol. 262, pp. 25–63, 2002. View at Google Scholar · View at Scopus
  21. T. P. Monath, “Lassa fever: review of epidemiology and epizootiology,” Bulletin of the World Health Organization, vol. 52, no. 4-5, pp. 577–592, 1975. View at Google Scholar · View at Scopus
  22. M. L. Kuns, “Epidemiology of Machupo virus infection. II. Ecological and control studies of hemorrhagic fever,” The American Journal of Tropical Medicine and Hygiene, vol. 14, no. 5, pp. 813–816, 1965. View at Google Scholar · View at Scopus
  23. W. G. Downs, C. R. Anderson, L. Spence, T. H. Aitken, and A. H. Greenhall, “Tacaribe virus, a new agent isolated from Artibeus bats and mosquitoes in Trinidad, West Indies,” The American Journal of Tropical Medicine and Hygiene, vol. 12, pp. 640–646, 1963. View at Google Scholar · View at Scopus
  24. A. Cogswell-Hawkinson, R. Bowen, S. James et al., “Tacaribe virus causes fatal infection of an ostensible reservoir host, the Jamaican fruit bat,” Journal of Virology, vol. 86, no. 10, pp. 5791–5799, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. C. J. Peters, “Human infection with arenaviruses in the Americas,” Current Topics in Microbiology and Immunology, vol. 262, pp. 65–74, 2002. View at Google Scholar · View at Scopus
  26. S. P. Fisher-Hoch, O. Tomori, A. Nasidi et al., “Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice,” The British Medical Journal, vol. 311, no. 7009, pp. 857–859, 1995. View at Publisher · View at Google Scholar · View at Scopus
  27. B. J. Stinebaugh, F. X. Schloeder, K. M. Johnson, R. B. Mackenzie, G. Entwisle, and E. de Alba, “Bolivian hemorrhagic fever. A report of four cases,” The American Journal of Medicine, vol. 40, no. 2, pp. 217–230, 1966. View at Publisher · View at Google Scholar · View at Scopus
  28. N. E. Yun and D. H. Walker, “Pathogenesis of Lassa fever,” Viruses, vol. 4, no. 10, pp. 2031–2048, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. S. C. Levis, M. C. Saavedra, C. Ceccoli et al., “Correlation between endogenous interferon and the clinical evolution of patients with Argentine hemorrhagic fever,” Journal of Interferon Research, vol. 5, no. 3, pp. 383–389, 1985. View at Publisher · View at Google Scholar · View at Scopus
  30. M. V. Heller, M. C. Saavedra, R. Falcoff, J. I. Maiztegui, and F. C. Molinas, “Increased tumor necrosis factor-α levels in Argentine hemorrhagic fever,” The Journal of Infectious Diseases, vol. 166, no. 5, pp. 1203–1204, 1992. View at Publisher · View at Google Scholar · View at Scopus
  31. Centers for Disease Control and Prevention (CDC), “Imported Lassa fever—New Jersey, 2004,” Morbidity and Mortality Weekly Report, vol. 53, no. 38, pp. 894–897, 2004. View at Google Scholar
  32. B. Elsner, E. Schwarz, O. G. Mando, J. Maiztegui, and A. Vilches, “Pathology of 12 fatal cases of Argentine hemorrhagic fever,” The American Journal of Tropical Medicine and Hygiene, vol. 22, no. 2, pp. 229–236, 1973. View at Google Scholar · View at Scopus
  33. J. I. Maiztegui, “Clinical and epidemiological patterns of Argentine haemorrhagic fever,” Bulletin of the World Health Organization, vol. 52, no. 4-5, pp. 567–575, 1975. View at Google Scholar · View at Scopus
  34. J. I. Maiztegui, K. T. McKee Jr., J. G. B. Oro et al., “Protective efficacy of a live attenuated vaccine against argentine hemorrhagic fever,” Journal of Infectious Diseases, vol. 177, no. 2, pp. 277–283, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. J. I. Maiztegui, N. J. Fernandez, and A. J. de Damilano, “Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome,” The Lancet, vol. 314, no. 8154, pp. 1216–1217, 1979. View at Publisher · View at Google Scholar · View at Scopus
  36. J. B. McCormick, I. J. King, P. A. Webb et al., “Lassa fever: effective therapy with ribavirin,” The New England Journal of Medicine, vol. 314, no. 1, pp. 20–26, 1986. View at Publisher · View at Google Scholar · View at Scopus
  37. K. T. McKee Jr., J. W. Huggins, C. J. Trahan, and B. G. Mahlandt, “Ribavirin prophylaxis and therapy for experimental Argentine hemorrhagic fever,” Antimicrobial Agents and Chemotherapy, vol. 32, no. 9, pp. 1304–1309, 1988. View at Publisher · View at Google Scholar · View at Scopus
  38. D. A. Enria, A. M. Briggiler, and Z. Sánchez, “Treatment of Argentine hemorrhagic fever,” Antiviral Research, vol. 78, no. 1, pp. 132–139, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Schmaljohn and S. T. Nichol, “Bunyaviridae,” Fields Virology, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, pp. 1741–1789, 2006. View at Google Scholar
  40. K. M. Jääskeläinen, P. Kaukinen, E. S. Minskaya et al., “Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon-beta promoter,” Journal of Medical Virology, vol. 79, no. 10, pp. 1527–1536, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Billecocq, M. Spiegel, P. Vialat et al., “NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription,” Journal of Virology, vol. 78, no. 18, pp. 9798–9806, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Blakqori, S. Delhaye, M. Habjan et al., “La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts,” Journal of Virology, vol. 81, no. 10, pp. 4991–4999, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. V. Cimica, N. A. Dalrymple, E. Roth, A. Nasonov, and E. R. Mackow, “An innate immunity-regulating virulence determinant is uniquely encoded by the Andes virus nucleocapsid protein,” mBio, vol. 5, no. 1, 2014. View at Publisher · View at Google Scholar
  44. J. Clement, P. Maes, K. Lagrou, M. van Ranst, and N. Lameire, “A unifying hypothesis and a single name for a complex globally emerging infection: Hantavirus disease,” European Journal of Clinical Microbiology & Infectious Diseases, vol. 31, no. 1, pp. 1–5, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. I. Gavrilovskaya, E. Gorbunova, V. Matthys, N. Dalrymple, and E. MacKow, “The role of the endothelium in HPS pathogenesis and potential therapeutic approaches,” Advances in Virology, vol. 2012, Article ID 467059, 12 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Liang, M. Guttieri, Å. Lundkvist, and C. Schmaljohn, “Baculovirus expression of a human G2-specific, neutralizing IgG monoclonal antibody to Puumala virus,” Virology, vol. 235, no. 2, pp. 252–260, 1997. View at Publisher · View at Google Scholar · View at Scopus
  47. S. R. Zaki, P. W. Greer, L. M. Coffield et al., “Hantavirus pulmonary syndrome: pathogenesis of an emerging infectious disease,” The American Journal of Pathology, vol. 146, no. 3, pp. 552–579, 1995. View at Google Scholar · View at Scopus
  48. J. A. Lednicky, “Hantaviruses. A short review,” Archives of Pathology & Laboratory Medicine, vol. 127, no. 1, pp. 30–35, 2003. View at Google Scholar · View at Scopus
  49. B. Settergren, “Nephropathia epidemica (hemorrhagic fever with renal syndrome) in Scandinavia,” Reviews of Infectious Diseases, vol. 13, no. 4, pp. 736–744, 1991. View at Publisher · View at Google Scholar · View at Scopus
  50. C. B. Zeimes, S. Quoilin, H. Henttonen et al., “Landscape and regional environmental analysis of the spatial distribution of hantavirus human cases in Europe,” Frontiers in Public Health, vol. 3, article 54, 2015. View at Publisher · View at Google Scholar
  51. T. F. Tsai, S. P. Bauer, D. R. Sasso et al., “Serological and virological evidence of a Hantaan virus-related enzootic in the United States,” The Journal of Infectious Diseases, vol. 152, no. 1, pp. 126–136, 1985. View at Publisher · View at Google Scholar · View at Scopus
  52. R. W. Cross, B. Waffa, A. Freeman et al., “Old world hantaviruses in rodents in New Orleans, Louisiana,” The American Journal of Tropical Medicine and Hygiene, vol. 90, no. 5, pp. 897–901, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. C. Schmaljohn and B. Hjelle, “Hantaviruses: a global disease problem,” Emerging Infectious Diseases, vol. 3, no. 2, pp. 95–104, 1997. View at Publisher · View at Google Scholar · View at Scopus
  54. C. B. Jonsson, L. T. M. Figueiredo, and O. Vapalahti, “A global perspective on hantavirus ecology, epidemiology, and disease,” Clinical Microbiology Reviews, vol. 23, no. 2, pp. 412–441, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. H. J. Kang, M. Y. Kosoy, S. K. Shrestha et al., “Genetic diversity of Thottapalayam virus, a hantavirus harbored by the Asian house shrew (Suncus murinus) in Nepal,” The American Journal of Tropical Medicine and Hygiene, vol. 85, no. 3, pp. 540–545, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. H. J. Kang, S. N. Bennett, L. Sumibcay et al., “Evolutionary insights from a genetically divergent hantavirus harbored by the European common mole (Talpa europaea),” PLoS ONE, vol. 4, no. 7, Article ID e6149, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Weiss, P. T. Witkowski, B. Auste et al., “Hantavirus in bat, Sierra Leone,” Emerging Infectious Diseases, vol. 18, no. 1, pp. 159–161, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. E. R. Kallio, J. Klingström, E. Gustafsson et al., “Prolonged survival of Puumala hantavirus outside the host: evidence for indirect transmission via the environment,” The Journal of General Virology, vol. 87, no. 8, pp. 2127–2134, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. O. Vapalahti, J. Mustonen, Å. Lundkvist, H. Henttonen, A. Plyusnin, and A. Vaheri, “Hantavirus infections in Europe,” The Lancet Infectious Diseases, vol. 3, no. 10, pp. 653–661, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. C. Martinez-Valdebenito, M. Calvo, C. Vial et al., “Person-to-person household and nosocomial transmission of Andes hantavirus, Southern Chile, 2011,” Emerging Infectious Diseases, vol. 20, no. 10, pp. 1629–1636, 2014. View at Publisher · View at Google Scholar · View at Scopus
  61. J. J. Smith and S. C. St. Jeor, “Three-week incubation period for hantavirus infection,” The Pediatric Infectious Disease Journal, vol. 23, no. 10, pp. 974–975, 2004. View at Publisher · View at Google Scholar · View at Scopus
  62. J. W. Hooper, A. M. Ferro, and V. Wahl-Jensen, “Immune serum produced by DNA vaccination protects hamsters against lethal respiratory challenge with Andes virus,” Journal of Virology, vol. 82, no. 3, pp. 1332–1338, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. C. Schmaljohn, “Vaccines for hantaviruses,” Vaccine, vol. 27, supplement 4, pp. D61–D64, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. T. Manigold and P. Vial, “Human hantavirus infections: epidemiology, clinical features, pathogenesis and immunology,” Swiss Medical Weekly, vol. 144, Article ID w13937, 2014. View at Publisher · View at Google Scholar · View at Scopus
  65. J. S. Duchin, F. T. Koster, C. J. Peters et al., “Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease,” The New England Journal of Medicine, vol. 330, no. 14, pp. 949–955, 1994. View at Publisher · View at Google Scholar · View at Scopus
  66. P. J. Padula, S. B. Colavecchia, V. P. Martinez et al., “Genetic diversity, distribution, and serological features of hantavirus infection in five countries in South America,” Journal of Clinical Microbiology, vol. 38, no. 8, pp. 3029–3035, 2000. View at Google Scholar · View at Scopus
  67. M. Bharadwaj, R. Nofchissey, D. Goade, F. Koster, and B. Hjelle, “Humoral immune responses in the hantavirus cardiopulmonary syndrome,” The Journal of Infectious Diseases, vol. 182, no. 1, pp. 43–48, 2000. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Mori, A. L. Rothman, I. Kurane et al., “High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome,” The Journal of Infectious Diseases, vol. 179, no. 2, pp. 295–302, 1999. View at Publisher · View at Google Scholar · View at Scopus
  69. K. B. Nolte, R. M. Feddersen, K. Foucar et al., “Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent,” Human Pathology, vol. 26, no. 1, pp. 110–120, 1995. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Mäkelä, J. Mustonen, I. Ala-Houhala et al., “Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-alpha(−308) G/A polymorphism,” The Journal of Infectious Diseases, vol. 186, no. 6, pp. 843–846, 2002. View at Publisher · View at Google Scholar · View at Scopus
  71. J. Mustonen, J. Partanen, M. Kanerva et al., “Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus,” Kidney International, vol. 49, no. 1, pp. 217–221, 1996. View at Publisher · View at Google Scholar · View at Scopus
  72. J. Mustonen, J. Partanen, M. Kanerva et al., “Association of HLA B27 with benign clinical course of nephropathia epidemica caused by Puumala hantavirus,” Scandinavian Journal of Immunology, vol. 47, no. 3, pp. 277–279, 1998. View at Publisher · View at Google Scholar · View at Scopus
  73. E. D. Kilpatrick, M. Terajima, F. T. Koster, M. D. Catalina, J. Cruz, and F. A. Ennis, “Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome,” The Journal of Immunology, vol. 172, no. 5, pp. 3297–3304, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. F. A. Ennis, J. Cruz, C. F. Spiropoulou et al., “Hantavirus pulmonary syndrome: CD8+ and CD4+ cytotoxic t lymphocytes to epitopes on Sin Nombre virus nucleocapsid protein isolated during acute illness,” Virology, vol. 238, no. 2, pp. 380–390, 1997. View at Publisher · View at Google Scholar · View at Scopus
  75. M. Terajima, D. Hayasaka, K. Maeda, and F. A. Ennis, “Immunopathogenesis of hantavirus pulmonary syndrome and hemorrhagic fever with renal syndrome: do CD8+ T cells trigger capillary leakage in viral hemorrhagic fevers?” Immunology Letters, vol. 113, no. 2, pp. 117–120, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. T. Tuuminen, E. Kekäläinen, S. Mäkelä et al., “Human CD8+ T cell memory generation in Puumala hantavirus infection occurs after the acute phase and is associated with boosting of EBV-specific CD8+ memory T cells,” Journal of Immunology, vol. 179, no. 3, pp. 1988–1995, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. A. A. Borges, G. M. Campos, M. L. Moreli et al., “Hantavirus cardiopulmonary syndrome: immune response and pathogenesis,” Microbes and Infection, vol. 8, no. 8, pp. 2324–2330, 2006. View at Publisher · View at Google Scholar · View at Scopus
  78. I. Gavrilovskaya, E. Gorbunova, F. Koster, and E. MacKow, “Elevated vegf levels in pulmonary edema fluid and pbmcs from patients with acute hantavirus Pulmonary syndrome,” Advances in Virology, vol. 2012, Article ID 674360, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  79. L. B. De Guerrero, M. C. Boxaca, and A. S. Parodi, “Experimental hemorrhagic fever in guinea pigs (Junín virus). Contagion and elimination of the virus,” Revista de la Asociacion Medica Argentina, vol. 79, no. 6, pp. 271–274, 1965. View at Google Scholar · View at Scopus
  80. R. H. Kenyon, D. E. Green, G. A. Eddy, and C. J. Peters, “Treatment of Junin virus-infected guinea pigs with immune serum: development of late neurological disease,” Journal of Medical Virology, vol. 20, no. 3, pp. 207–218, 1986. View at Publisher · View at Google Scholar · View at Scopus
  81. R. H. Kenyon, D. E. Green, J. I. Maiztegui, and C. J. Peters, “Viral strain dependent differences in experimental Argentine hemorrhagic fever (Junin virus) infection of guinea pigs,” Intervirology, vol. 29, no. 3, pp. 133–143, 1988. View at Google Scholar · View at Scopus
  82. S. R. Samoilovich, M. A. Calello, R. P. Laguens, and M. C. Weissenbacher, “Long-term protection against Argentine hemorrhagic fever in Tacaribe virus infected marmosets: virologic and histopathologic findings,” Journal of Medical Virology, vol. 24, no. 2, pp. 229–236, 1988. View at Publisher · View at Google Scholar · View at Scopus
  83. N. E. Yun, N. S. Linde, N. Dziuba et al., “Pathogenesis of XJ and Romero strains of Junin virus in two strains of guinea pigs,” The American Journal of Tropical Medicine and Hygiene, vol. 79, no. 2, pp. 275–282, 2008. View at Google Scholar · View at Scopus
  84. R. H. Kenyon, K. T. McKee Jr., J. I. Maiztegui, D. E. Green, and C. J. Peters, “Heterogeneity of Junin virus strains,” Medical Microbiology and Immunology, vol. 175, no. 2-3, pp. 169–172, 1986. View at Publisher · View at Google Scholar · View at Scopus
  85. N. A. Candurra, E. B. Damonte, and C. E. Coto, “Antigenic relationships between attenuated and pathogenic strains of Junin virus,” Journal of Medical Virology, vol. 27, no. 2, pp. 145–150, 1989. View at Publisher · View at Google Scholar · View at Scopus
  86. M. C. Weissenbacher, L. B. de Guerrero, and M. C. Boxaca, “Experimental biology and pathogenesis of Junin virus infection in animals and man,” Bulletin of the World Health Organization, vol. 52, no. 4-5, pp. 507–515, 1975. View at Google Scholar · View at Scopus
  87. J. R. Oubina, G. Carballal, C. M. Videla, and P. M. Cossio, “The guinea pig model for Argentine hemorrhagic fever,” American Journal of Tropical Medicine and Hygiene, vol. 33, no. 6, pp. 1251–1257, 1984. View at Google Scholar · View at Scopus
  88. C. B. Dejean, B. L. Ayerra, and A. R. Teyssie, “Interferon response in the guinea pig infected with Junin virus,” Journal of Medical Virology, vol. 23, no. 1, pp. 83–91, 1987. View at Publisher · View at Google Scholar · View at Scopus
  89. N. López, L. Scolaro, C. Rossi et al., “Homologous and heterologous glycoproteins induce protection against Junin virus challenge in guinea pigs,” The Journal of General Virology, vol. 81, no. 5, pp. 1273–1281, 2000. View at Google Scholar · View at Scopus
  90. A. V. Seregin, N. E. Yun, A. L. Poussard et al., “TC83 replicon vectored vaccine provides protection against Junin virus in guinea pigs,” Vaccine, vol. 28, no. 30, pp. 4713–4718, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. B. Cresta, P. Padula, and Z. M. D. M. Segovia, “Biological properties of Junin virus proteins. I. Identification of the immunogenic glycoprotein,” Intervirology, vol. 13, no. 5, pp. 284–288, 1980. View at Publisher · View at Google Scholar · View at Scopus
  92. B. B. Gowen, T. L. Juelich, E. J. Sefing et al., “Favipiravir (T-705) inhibits Junin virus infection and reduces mortality in a guinea pig model of Argentine hemorrhagic fever,” PLoS Neglected Tropical Diseases, vol. 7, no. 12, Article ID e2614, 2013. View at Publisher · View at Google Scholar · View at Scopus
  93. M. Salazar, N. E. Yun, A. L. Poussard et al., “Effect of ribavirin on junin virus infection in guinea pigs,” Zoonoses and Public Health, vol. 59, no. 4, pp. 278–285, 2012. View at Publisher · View at Google Scholar · View at Scopus
  94. C. J. Peters, R. W. Kuehne, R. R. Mercado, R. H. le Bow, R. O. Spertzel, and P. A. Webb, “Hemorrhagic fever in Cochabamba, Bolivia, 1971,” American Journal of Epidemiology, vol. 99, no. 6, pp. 425–433, 1974. View at Google Scholar · View at Scopus
  95. M. C. Weissenbacher, C. E. Coto, and M. A. Calello, “Cross-protection between Tacaribe complex viruses. Presence of neutralizing antibodies against Junin virus (Argentine hemorrhagic fever) in guinea pigs infected with Tacaribe virus,” Intervirology, vol. 6, pp. 42–49, 1975. View at Google Scholar · View at Scopus
  96. P. A. Webb, G. Justines, and K. M. Johnson, “Infection of wild and laboratory animals with Machupo and Latino viruses,” Bulletin of the World Health Organization, vol. 52, no. 4-5, pp. 493–499, 1975. View at Google Scholar · View at Scopus
  97. T. M. Bell, C. I. Shaia, T. E. Bunton et al., “Pathology of experimental machupo virus infection, chicava strain, in cynomolgus macaques (Macaca fascicularis) by intramuscular and aerosol exposure,” Veterinary Pathology, vol. 52, no. 1, pp. 26–37, 2015. View at Publisher · View at Google Scholar · View at Scopus
  98. W. C. Hall, T. W. Geisbert, J. W. Huggins, and P. B. Jahrling, “Experimental infection of guinea pigs with Venezuelan hemorrhagic fever virus (Guanarito): a model of human disease,” The American Journal of Tropical Medicine and Hygiene, vol. 55, no. 1, pp. 81–88, 1996. View at Google Scholar · View at Scopus
  99. R. B. Tesh, P. B. Jahrling, R. Salas, and R. E. Shope, “Description of Guanarito virus (Arenaviridae: Arenavirus), the etiologic agent of Venezuelan hemorrhagic fever,” The American Journal of Tropical Medicine and Hygiene, vol. 50, no. 4, pp. 452–459, 1994. View at Google Scholar · View at Scopus
  100. H. Wulff and K. M. Johnson, “Immunoglobulin M and G responses measured by immunofluorescence in patients with Lassa or Marburg virus infections,” Bulletin of the World Health Organization, vol. 57, no. 4, pp. 631–635, 1979. View at Google Scholar · View at Scopus
  101. D. Safronetz, J. E. Strong, F. Feldmann et al., “A recently isolated Lassa virus from Mali demonstrates atypical clinical disease manifestations and decreased virulence in cynomolgus macaques,” The Journal of Infectious Diseases, vol. 207, no. 8, pp. 1316–1327, 2013. View at Publisher · View at Google Scholar · View at Scopus
  102. P. B. Jahrling, J. D. Frame, S. B. Smith, and M. H. Monson, “Endemic Lassa fever in Liberia. III. Characterization of Lassa virus isolates,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 79, no. 3, pp. 374–379, 1985. View at Publisher · View at Google Scholar · View at Scopus
  103. S. F. Emonet, A. V. Seregin, N. E. Yun et al., “Rescue from cloned cDNAs and in vivo characterization of recombinant pathogenic Romero and live-attenuated Candid #1 strains of Junin virus, the causative agent of Argentine hemorrhagic fever disease,” Journal of Virology, vol. 85, no. 4, pp. 1473–1483, 2011. View at Publisher · View at Google Scholar
  104. M. I. Berria, L. F. Gutman Frugone, R. Girola, and J. G. Barrera Oro, “Immunological studies with Junin virus. I. Formation of antibodies in guinea pigs inoculated with live viruses,” Medicina, vol. 27, no. 2, pp. 93–98, 1967. View at Google Scholar · View at Scopus
  105. A. S. Parodi, D. J. Greenway, H. R. Rugiero et al., “Concerning the epidemic outbreak in Junin,” El Día Médico, vol. 30, no. 62, pp. 2300–2301, 1958. View at Google Scholar · View at Scopus
  106. K. T. McKee Jr., B. G. Mahlandt, J. I. Maiztegui, G. A. Eddy, and C. J. Peters, “Experimental Argentine hemorrhagic fever in rhesus macaques: viral strain-dependent clinical response,” The Journal of Infectious Diseases, vol. 152, no. 1, pp. 218–221, 1985. View at Publisher · View at Google Scholar · View at Scopus
  107. K. T. McKee Jr., J. G. Oro, A. I. Kuehne, J. A. Spisso, and B. G. Mahlandt, “Candid No. 1 Argentine hemorrhagic fever vaccine protects against lethal Junin virus challenge in rhesus macaques,” Intervirology, vol. 34, no. 3, pp. 154–163, 1992. View at Google Scholar · View at Scopus
  108. B. H. Bird, K. A. Dodd, B. R. Erickson et al., “Severe hemorrhagic fever in strain 13/N guinea pigs infected with Lujo virus,” PLoS Neglected Tropical Diseases, vol. 6, no. 8, Article ID e1801, 2012. View at Publisher · View at Google Scholar · View at Scopus
  109. P. B. Jahrling, S. Smith, R. A. Hesse, and J. B. Rhoderick, “Pathogenesis of Lassa virus infection in guinea pigs,” Infection and Immunity, vol. 37, no. 2, pp. 771–778, 1982. View at Google Scholar · View at Scopus
  110. D. H. Walker, H. Wulff, J. V. Lange, and F. A. Murphy, “Comparative pathology of Lassa virus infection in monkeys, guinea pigs, and Mastomys natalensis,” Bulletin of the World Health Organization, vol. 52, no. 4-5, pp. 523–534, 1975. View at Google Scholar · View at Scopus
  111. P. B. Jahrling, R. A. Hesse, G. A. Eddy, K. M. Johnson, R. T. Callis, and E. L. Stephen, “Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin,” The Journal of Infectious Diseases, vol. 141, no. 5, pp. 580–589, 1980. View at Publisher · View at Google Scholar · View at Scopus
  112. R. T. Callis, P. B. Jahrling, and A. DePaoli, “Pathology of Lassa virus infection in the rhesus monkey,” The American Journal of Tropical Medicine and Hygiene, vol. 31, no. 5, pp. 1038–1045, 1982. View at Google Scholar · View at Scopus
  113. J. V. Lange, S. W. Mitchell, J. B. McCormick, D. H. Walker, B. L. Evatt, and R. R. Ramsey, “Kinetic study of platelets and fibrinogen in Lassa virus-infected monkeys and early pathologic events in Mopeia virus-infected monkeys,” The American Journal of Tropical Medicine and Hygiene, vol. 34, no. 5, pp. 999–1007, 1985. View at Google Scholar · View at Scopus
  114. S. P. Fisher-Hoch, S. W. Mitchell, D. R. Sasso, J. V. Lange, R. Ramsey, and J. B. McCormick, “Physiological and immunologic disturbances associated with shock in a primate model of Lassa fever,” The Journal of Infectious Diseases, vol. 155, no. 3, pp. 465–474, 1987. View at Publisher · View at Google Scholar · View at Scopus
  115. L. E. Hensley, M. A. Smith, J. B. Geisbert et al., “Pathogenesis of lassa fever in cynomolgus macaques,” Virology Journal, vol. 8, article 205, 2011. View at Publisher · View at Google Scholar · View at Scopus
  116. E. H. Stephenson, E. W. Larson, and J. W. Dominik, “Effect of environmental factors on aerosol-induced Lassa virus infection,” Journal of Medical Virology, vol. 14, no. 4, pp. 295–303, 1984. View at Publisher · View at Google Scholar · View at Scopus
  117. S. Malhotra, J. Y. Yen, A. N. Honko et al., “Transcriptional profiling of the circulating immune response to lassa virus in an aerosol model of exposure,” PLoS Neglected Tropical Diseases, vol. 7, no. 4, Article ID e2171, 2013. View at Publisher · View at Google Scholar · View at Scopus
  118. R. Carrion Jr., K. Brasky, K. Mansfield et al., “Lassa virus infection in experimentally infected marmosets: liver pathology and immunophenotypic alterations in target tissues,” Journal of Virology, vol. 81, no. 12, pp. 6482–6490, 2007. View at Publisher · View at Google Scholar · View at Scopus
  119. I. S. Lukashevich, R. Carrion Jr., M. S. Salvato et al., “Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates,” Vaccine, vol. 26, no. 41, pp. 5246–5254, 2008. View at Publisher · View at Google Scholar · View at Scopus
  120. A. L. Rasmussen, N. Tchitchek, D. Safronetz et al., “Delayed inflammatory and cell death responses are associated with reduced pathogenicity in lujo virus-infected cynomolgus macaques,” Journal of Virology, vol. 89, no. 5, pp. 2543–2552, 2015. View at Publisher · View at Google Scholar · View at Scopus
  121. C. G. Albariño, B. H. Bird, A. K. Chakrabarti et al., “The major determinant of attenuation in mice of the candid1 vaccine for argentine hemorrhagic fever is located in the G2 glycoprotein transmembrane domain,” Journal of Virology, vol. 85, no. 19, pp. 10404–10408, 2011. View at Publisher · View at Google Scholar · View at Scopus
  122. O. A. Kolokoltsova, N. E. Yun, A. L. Poussard et al., “Mice lacking alpha/beta and gamma interferon receptors are susceptible to Junin virus infection,” Journal of Virology, vol. 84, no. 24, pp. 13063–13067, 2010. View at Publisher · View at Google Scholar · View at Scopus
  123. D. E. Green, B. G. Mahlandt, and K. T. McKee Jr., “Experimental Argentine hemorrhagic fever in rhesus macaques: virus-specific variations in pathology,” Journal of Medical Virology, vol. 22, no. 2, pp. 113–133, 1987. View at Publisher · View at Google Scholar · View at Scopus
  124. K. T. McKee Jr., B. G. Mahlandt, J. I. Maiztegui, D. E. Green, and C. J. Peters, “Virus-specific factors in experimental Argentine hemorrhagic fever in rhesus macaques,” Journal of Medical Virology, vol. 22, no. 2, pp. 99–111, 1987. View at Publisher · View at Google Scholar · View at Scopus
  125. R. H. Kenyon, K. T. McKee Jr., P. M. Zack et al., “Aerosol infection of rhesus macaques with Junin virus,” Intervirology, vol. 33, no. 1, pp. 23–31, 1992. View at Google Scholar · View at Scopus
  126. K. T. McKee Jr., J. G. B. Oro, A. I. Kuehne, J. A. Spisso, and B. G. Mahlandt, “Safety and immunogenicity of a live-attenuated Junin (Argentine hemorrhagic fever) vaccine in rhesus macaques,” The American Journal of Tropical Medicine and Hygiene, vol. 48, no. 3, pp. 403–411, 1993. View at Google Scholar · View at Scopus
  127. M. C. Weissenbacher, M. A. Calello, O. J. Colillas, S. N. Rondinone, and M. J. Frigerio, “Argentine hemorrhagic fever: a primate model,” Intervirology, vol. 11, no. 6, pp. 363–365, 1979. View at Publisher · View at Google Scholar · View at Scopus
  128. M. J. Frigerio, S. N. Rondinone, M. A. Callelo, E. R. Paradisi, and M. C. Weissenbacher, “Junin virus infection of Calithrix jacchus: haematological findings,” Acta Virologica, vol. 26, no. 4, pp. 270–278, 1982. View at Google Scholar · View at Scopus
  129. F. C. Molinas, E. Giavedoni, M. J. Frigerio, M. A. Calello, J. A. Barcat, and M. C. Weissenbacher, “Alteration of blood coagulation and complement system in neotropical primates infected with junin virus,” Journal of Medical Virology, vol. 12, no. 4, pp. 281–292, 1983. View at Publisher · View at Google Scholar · View at Scopus
  130. P. H. Gonzalez, R. P. Laguens, M. J. Frigerio, M. A. Calello, and M. C. Weissenbacher, “Junin virus infection of Callithrix jacchus: pathologic features,” The American Journal of Tropical Medicine and Hygiene, vol. 32, no. 2, pp. 417–423, 1983. View at Google Scholar · View at Scopus
  131. A. D. Vitullo and M. S. Merani, “Is vertical transmission sufficient to maintain Junin virus in nature?” The Journal of General Virology, vol. 69, pp. 1437–1440, 1988. View at Google Scholar · View at Scopus
  132. A. D. Vitullo and M. S. Merani, “Vertical transmission of Junin virus in experimentally infected adult Calomys musculinus,” Intervirology, vol. 31, no. 6, pp. 339–344, 1990. View at Google Scholar · View at Scopus
  133. J. E. Childs and C. J. Peter, “Ecology and epidemiology of arenaviruses and their hosts,” in The Arenaviridae, M. Salvato, Ed., pp. 331–384, Plenum Press, New York, NY, USA, 1993. View at Google Scholar
  134. L. E. Alche and C. E. Coto, “Differentiation of Junin virus and antigenic variants isolated in vivo by kinetic neutralization assays,” The Journal of General Virology, vol. 69, no. 8, pp. 2123–2127, 1988. View at Publisher · View at Google Scholar · View at Scopus
  135. M. Patterson, A. Seregin, C. Huang et al., “Rescue of a recombinant Machupo virus from cloned cDNAs and in vivo characterization in interferon (αβ/γ) receptor double knockout mice,” Journal of Virology, vol. 88, no. 4, pp. 1914–1923, 2014. View at Publisher · View at Google Scholar · View at Scopus
  136. S. B. Bradfute, K. S. Stuthman, A. C. Shurtleff, and S. Bavari, “A STAT-1 knockout mouse model for Machupo virus pathogenesis,” Virology Journal, vol. 8, article 300, 2011. View at Publisher · View at Google Scholar · View at Scopus
  137. G. A. Eddy, S. K. Scott, F. S. Wagner, and O. M. Brand, “Pathogenesis of Machupo virus infection in primates,” Bulletin of the World Health Organization, vol. 52, no. 4-5, pp. 517–521, 1975. View at Google Scholar · View at Scopus
  138. M. D. Kastello, G. A. Eddy, and R. W. Kuehne, “A rhesus monkey model for the study of Bolivian hemorrhagic fever,” The Journal of Infectious Diseases, vol. 133, no. 1, pp. 57–62, 1976. View at Publisher · View at Google Scholar · View at Scopus
  139. C. G. McLeod, J. L. Stookey, G. A. Eddy, and S. K. Scott, “Pathology of chronic bolivian hemorrhagic fever in the rhesus monkey,” The American Journal of Pathology, vol. 84, no. 2, pp. 211–224, 1976. View at Google Scholar · View at Scopus
  140. S. K. Scott, R. L. Hickman, C. M. Lang, G. A. Eddy, D. E. Hilmas, and R. O. Spertzel, “Studies of the coagulation system and blood pressure during experimental Bolivian hemorrhagic fever in rhesus monkeys,” The American Journal of Tropical Medicine and Hygiene, vol. 27, no. 6, pp. 1232–1239, 1978. View at Google Scholar · View at Scopus
  141. G. Justines and K. M. Johnson, “Immune tolerance in Calomys callosus infected with Machupo virus,” Nature, vol. 222, no. 5198, pp. 1090–1091, 1969. View at Publisher · View at Google Scholar · View at Scopus
  142. M. J. Buchmeier and W. E. Rawls, “Variation between strains of hamsters in the lethality of Pichinde virus infections,” Infection and Immunity, vol. 16, no. 2, pp. 413–421, 1977. View at Google Scholar · View at Scopus
  143. D. F. Smee, J. Gilbert, J. A. Leonhardt, B. B. Barnett, J. H. Huggins, and R. W. Sidwell, “Treatment of lethal pichinde virus infections in weanling LVG/Lak hamsters with ribavirin, ribamidine, selenazofurin, and ampligen,” Antiviral Research, vol. 20, no. 1, pp. 57–70, 1993. View at Publisher · View at Google Scholar · View at Scopus
  144. P. B. Jahrling, R. A. Hesse, J. B. Rhoderick, M. A. Elwell, and J. B. Moe, “Pathogenesis of a pichinde virus strain adapted to produce lethal infections in guinea pigs,” Infection and Immunity, vol. 32, no. 2, pp. 872–880, 1981. View at Google Scholar · View at Scopus
  145. J. Munoz, “Comparison between Hartley and strain 13 guinea pigs—antibody production and delayed hypersensitivity,” The Journal of Immunology, vol. 99, no. 1, pp. 31–39, 1967. View at Google Scholar · View at Scopus
  146. M. Patterson, T. Koma, A. Seregin et al., “A substitution in the transmembrane region of the glycoprotein leads to an unstable attenuation of machupo virus,” Journal of Virology, vol. 88, no. 18, pp. 10995–10999, 2014. View at Publisher · View at Google Scholar · View at Scopus
  147. N. E. Yun, A. L. Poussard, A. V. Seregin et al., “Functional interferon system is required for clearance of lassa virus,” Journal of Virology, vol. 86, no. 6, pp. 3389–3392, 2012. View at Publisher · View at Google Scholar · View at Scopus
  148. T. Rieger, D. Merkler, and S. Günther, “Infection of type I interferon receptor-deficient mice with various old world arenaviruses: a model for studying virulence and host species barriers,” PLoS ONE, vol. 8, no. 8, Article ID e72290, 2013. View at Publisher · View at Google Scholar · View at Scopus
  149. N. E. Yun, A. V. Seregin, D. H. Walker et al., “Mice lacking functional STAT1 are highly susceptible to lethal infection with Lassa virus,” Journal of Virology, vol. 87, no. 19, pp. 10908–10911, 2013. View at Publisher · View at Google Scholar · View at Scopus
  150. L. Flatz, T. Rieger, D. Merkler et al., “T cell-dependence of lassa fever pathogenesis,” PLoS Pathogens, vol. 6, no. 3, Article ID e1000836, 2010. View at Publisher · View at Google Scholar · View at Scopus
  151. J. Abraham, J. A. Kwong, C. G. Albarino et al., “Host-species transferrin receptor 1 orthologs are cellular receptors for nonpathogenic new world clade B arenaviruses,” PLoS Pathogens, vol. 5, no. 4, Article ID e1000358, 2009. View at Publisher · View at Google Scholar · View at Scopus
  152. S. P. Fisher-Hoch and J. B. McCormick, “Pathophysiology and treatment of Lassa fever,” Current Topics in Microbiology and Immunology, vol. 134, pp. 231–239, 1987. View at Google Scholar · View at Scopus
  153. M. P. Kiley, J. V. Lange, and K. M. Johnson, “Protection of rhesus monkeys from Lassa virus by immunisation with closely related Arenavirus,” The Lancet, vol. 314, no. 8145, p. 738, 1979. View at Publisher · View at Google Scholar · View at Scopus
  154. S. P. Fisher-Hoch, J. B. McCormick, D. Auperin et al., “Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 1, pp. 317–321, 1989. View at Publisher · View at Google Scholar · View at Scopus
  155. S. P. Fisher-Hoch, L. Hutwagner, B. Brown, and J. B. McCormick, “Effective vaccine for Lassa fever,” Journal of Virology, vol. 74, no. 15, pp. 6777–6783, 2000. View at Publisher · View at Google Scholar · View at Scopus
  156. J. B. McCormick, S. W. Mitchell, M. P. Kiley, S. Ruo, and S. P. Fisher-Hoch, “Inactivated Lassa virus elicits a non protective immune response in rhesus monkeys,” Journal of Medical Virology, vol. 37, no. 1, pp. 1–7, 1992. View at Publisher · View at Google Scholar · View at Scopus
  157. P. B. Jahrling and C. J. Peters, “Passive antibody therapy of lassa fever in cynomolgus monkeys: importance of neutralizing antibody and lassa virus strain,” Infection and Immunity, vol. 44, no. 2, pp. 528–533, 1984. View at Google Scholar · View at Scopus
  158. P. B. Jahrling, C. J. Peters, and E. L. Stephen, “Enhanced treatment of lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys,” The Journal of Infectious Diseases, vol. 149, no. 3, pp. 420–427, 1984. View at Publisher · View at Google Scholar · View at Scopus
  159. E. L. Stephen and P. B. Jahrling, “Experimental Lassa fever virus infection successfully treated with ribavirin,” The Lancet, vol. 313, no. 8110, pp. 268–269, 1979. View at Publisher · View at Google Scholar · View at Scopus
  160. S. Baize, P. Marianneau, P. Loth et al., “Early and strong immune responses are associated with control of viral replication and recovery in Lassa virus-infected cynomolgus monkeys,” Journal of Virology, vol. 83, no. 11, pp. 5890–5903, 2009. View at Publisher · View at Google Scholar · View at Scopus
  161. M. C. Weissenbacher, C. E. Coto, M. A. Calello, S. N. Rondinone, E. B. Damonte, and M. J. Frigerio, “Cross-protection in nonhuman primates against Argentine hemorrhagic fever,” Infection and Immunity, vol. 35, no. 2, pp. 425–430, 1982. View at Google Scholar · View at Scopus
  162. M. M. Avila, M. J. Frigerio, E. L. Weber et al., “Attenuated Junin virus infection in Callithrix jacchus,” Journal of Medical Virology, vol. 15, no. 1, pp. 93–100, 1985. View at Publisher · View at Google Scholar · View at Scopus
  163. M. M. Avila, S. R. Samoilovich, and R. P. Laguens, “Protection of Junin virus-infected marmosets by passive administration of immune serum: association with late neurologic signs,” Journal of Medical Virology, vol. 21, no. 1, pp. 67–74, 1987. View at Publisher · View at Google Scholar · View at Scopus
  164. M. C. Weissenbacher, M. A. Calello, M. S. Merani, J. B. McCormick, and M. Rodriguez, “Therapeutic effect of the antiviral agent Ribavirin in Junin virus infection of primates,” Journal of Medical Virology, vol. 20, no. 3, pp. 261–267, 1986. View at Publisher · View at Google Scholar · View at Scopus
  165. M. C. Weissenbacher, M. M. Avila, M. A. Calello, M. S. Merani, J. B. McCormick, and M. Rodriguez, “Effect of Ribavirin and immune serum on Junin virus-infected primates,” Medical Microbiology and Immunology, vol. 175, no. 2-3, pp. 183–186, 1986. View at Publisher · View at Google Scholar · View at Scopus
  166. A. A. Evseev, V. I. Dvoretskaia, G. V. Bogatikov, V. A. Pshenichnov, and R. M. Mustafin, “Experimental Lassa fever in hamadryas baboons,” Voprosy Virusologii, vol. 36, pp. 150–152, 1991. View at Google Scholar
  167. F. S. Wagner, G. A. Eddy, and O. M. Brand, “The African green monkey as an alternate primate host for studying Machupo virus infection,” The American Journal of Tropical Medicine and Hygiene, vol. 26, no. 1, pp. 159–162, 1977. View at Google Scholar · View at Scopus
  168. C. G. McLeod Jr., J. L. Stookey, J. D. White, G. A. Eddy, and G. A. Fry, “Pathology of Bolivian hemorrhagic fever in the African green monkey,” The American Journal of Tropical Medicine and Hygiene, vol. 27, no. 4, pp. 822–826, 1978. View at Google Scholar · View at Scopus
  169. V. I. Dvoretskaya, G. V. Bogatikov, V. A. Pshenichnov, and A. A. Evseev, “The therapeutic efficacy of ribamydil and virasol in experimental Lassa fever in monkeys,” Voprosy Virusologii, vol. 36, no. 1, pp. 55–57, 1991. View at Google Scholar · View at Scopus
  170. V. P. Krasnianskiǐ, N. V. Potryvaeva, I. V. Borisevich, V. N. Gradoboev, T. P. Pashanina, and V. A. Pshenichnov, “A trial to produce an inactivated Lassa fever vaccine,” Voprosy Virusologii, vol. 38, no. 6, pp. 276–279, 1993. View at Google Scholar · View at Scopus
  171. R. Carrion Jr. and J. L. Patterson, “An animal model that reflects human disease: the common marmoset (Callithrix jacchus),” Current Opinion in Virology, vol. 2, no. 3, pp. 357–362, 2012. View at Publisher · View at Google Scholar · View at Scopus
  172. H. Trapido and C. Sanmartín, “Pichinde virus, a new virus of the Tacaribe group from Colombia,” The American Journal of Tropical Medicine and Hygiene, vol. 20, no. 4, pp. 631–641, 1971. View at Google Scholar · View at Scopus
  173. K. E. Wright, K. L. Rosenthal, and W. E. Rawls, “Association of reduced interleukin-2 production with genetic susceptibility to Pichinde virus in inbred strains of hamsters,” Archives of Virology, vol. 92, no. 3-4, pp. 197–209, 1987. View at Publisher · View at Google Scholar · View at Scopus
  174. B. B. Gowen, D. L. Barnard, D. F. Smee et al., “Interferon alfacon-1 protects hamsters from lethal Pichinde virus infection,” Antimicrobial Agents and Chemotherapy, vol. 49, no. 6, pp. 2378–2386, 2005. View at Publisher · View at Google Scholar · View at Scopus
  175. Y. Liang, S. Lan, and H. Ly, “Molecular determinants of pichinde virus infection of guinea pigs—a small animal model system for arenaviral hemorrhagic fevers,” Annals of the New York Academy of Sciences, vol. 1171, no. 1, pp. E65–E74, 2009. View at Publisher · View at Google Scholar · View at Scopus
  176. H. Ebihara, K. Yoshimatsu, M. Ogino et al., “Pathogenicity of Hantaan virus in newborn mice: genetic reassortant study demonstrating that a single amino acid change in glycoprotein G1 is related to virulence,” Journal of Virology, vol. 74, no. 19, pp. 9245–9255, 2000. View at Publisher · View at Google Scholar · View at Scopus
  177. G. R. Kim and K. T. McKee Jr., “Pathogenesis of Hantaan virus infection in suckling mice: clinical, virologic, and serologic observations,” The American Journal of Tropical Medicine and Hygiene, vol. 34, no. 2, pp. 388–395, 1985. View at Google Scholar · View at Scopus
  178. K. T. McKee Jr., G. R. Kim, D. E. Green, and C. J. Peters, “Hantaan virus infection in suckling mice: virologic and pathologic correlates,” Journal of Medical Virology, vol. 17, no. 2, pp. 107–117, 1985. View at Publisher · View at Google Scholar · View at Scopus
  179. Y. C. Yoo, K. Yoshimatsu, R. Yoshida, M. Tamura, I. Azuma, and J. Arikawa, “Comparison of virulence between Seoul virus strain SR-11 and Hantaan virus strain 76–118 of hantaviruses in newborn mice,” Microbiology and Immunology, vol. 37, no. 7, pp. 557–562, 1993. View at Publisher · View at Google Scholar · View at Scopus
  180. J. W. Huggins, G. R. Kim, O. M. Brand, and K. T. McKee Jr., “Ribavirin therapy for Hantaan virus infection in suckling mice,” The Journal of Infectious Diseases, vol. 153, no. 3, pp. 489–497, 1986. View at Publisher · View at Google Scholar · View at Scopus
  181. X.-K. Zhang, I. Takashima, F. Mori, and N. Hashimoto, “Comparison of virulence between two strains of Rattus serotype hemorrhagic fever with renal syndrome (HFRS) virus in newborn rats,” Microbiology and Immunology, vol. 33, no. 3, pp. 195–205, 1989. View at Publisher · View at Google Scholar · View at Scopus
  182. T. Yamanouchi, K. Domae, O. Tanishita et al., “Experimental infection in newborn mice and rats by hemorrhagic fever with renal syndrome (HFRS) virus,” Microbiology and Immunology, vol. 28, no. 12, pp. 1345–1353, 1984. View at Publisher · View at Google Scholar · View at Scopus
  183. K. Araki, K. Yoshimatsu, B.-H. Lee, H. Kariwa, I. Takashima, and J. Arikawa, “A new model of Hantaan virus persistence in mice: the balance between HTNV infection and CD8+ T-cell responses,” Virology, vol. 322, no. 2, pp. 318–327, 2004. View at Publisher · View at Google Scholar · View at Scopus
  184. T. Kurata, T. F. Tsai, S. P. Bauer, and J. B. McCormick, “Immunofluorescence studies of disseminated Hantaan virus infection of suckling mice,” Infection and Immunity, vol. 41, no. 1, pp. 391–398, 1983. View at Google Scholar · View at Scopus
  185. T. F. Tsai, S. Bauer, J. B. McCormick, and T. Kurata, “Intracerebral inoculation of suckling mice with Hantaan virus,” The Lancet, vol. 320, no. 8296, pp. 503–504, 1982. View at Publisher · View at Google Scholar · View at Scopus
  186. M. Tamura, H. Asada, K. Kondo, O. Tanishita, T. Kurata, and K. Yamanishi, “Pathogenesis of Hantaan virus in mice,” The Journal of General Virology, vol. 70, part 11, pp. 2897–2906, 1989. View at Publisher · View at Google Scholar · View at Scopus
  187. H. W. Lee, P. W. Lee, L. J. Baek, C. K. Song, and I. W. Seong, “Intraspecific transmission of Hantaan virus, etiologic agent of Korean hemorrhagic fever, in the rodent Apodemus agrarius,” The American Journal of Tropical Medicine and Hygiene, vol. 30, no. 5, pp. 1106–1112, 1981. View at Google Scholar · View at Scopus
  188. J. W. Hooper, D. M. Custer, E. Thompson, and C. S. Schmaljohn, “DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys,” Journal of Virology, vol. 75, no. 18, pp. 8469–8477, 2001. View at Publisher · View at Google Scholar · View at Scopus
  189. C. S. Schmaljohn, Y.-K. Chu, A. L. Schmaljohn, and J. M. Dalrymple, “Antigenic subunits of hantaan virus expressed by baculovirus and vaccinia virus recombinants,” Journal of Virology, vol. 64, no. 7, pp. 3162–3170, 1990. View at Google Scholar · View at Scopus
  190. Y.-K. Chu, G. B. Jennings, and C. S. Schmaljohn, “A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus,” Journal of Virology, vol. 69, no. 10, pp. 6417–6423, 1995. View at Google Scholar · View at Scopus
  191. R. Yanagihara, H. L. Amyx, and D. C. Gajdusek, “Experimental infection with Puumala virus, the etiologic agent of nephropathia epidemica, in bank voles (Clethrionomys glareolus),” Journal of Virology, vol. 55, no. 1, pp. 34–38, 1985. View at Google Scholar · View at Scopus
  192. J. Groen, M. Gerding, J. P. Koeman et al., “A macaque model for hantavirus infection,” The Journal of Infectious Diseases, vol. 172, no. 1, pp. 38–44, 1995. View at Publisher · View at Google Scholar · View at Scopus
  193. J. Klingström, J. Hardestam, and Å. Lundkvist, “Dobrava, but not Saaremaa, hantavirus is lethal and induces nitric oxide production in suckling mice,” Microbes and Infection, vol. 8, no. 3, pp. 728–737, 2006. View at Publisher · View at Google Scholar · View at Scopus
  194. S. R. Compton, R. O. Jacoby, F. X. Paturzo, and A. L. Smith, “Persistent Seoul virus infection in Lewis rats,” Archives of Virology, vol. 149, no. 7, pp. 1325–1339, 2004. View at Google Scholar · View at Scopus
  195. S. L. Klein, B. H. Bird, and G. E. Glass, “Sex differences in Seoul virus infection are not related to adult sex steroid concentrations in Norway rats,” Journal of Virology, vol. 74, no. 17, pp. 8213–8217, 2000. View at Publisher · View at Google Scholar · View at Scopus
  196. J. W. Hooper, K. I. Kamrud, F. Elgh, D. Custer, and C. S. Schmaljohn, “DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against seoul virus infection,” Virology, vol. 255, no. 2, pp. 269–278, 1999. View at Publisher · View at Google Scholar · View at Scopus
  197. J. W. Hooper, T. Larsen, D. M. Custer, and C. S. Schmaljohn, “A lethal disease model for hantavirus pulmonary syndrome,” Virology, vol. 289, no. 1, pp. 6–14, 2001. View at Publisher · View at Google Scholar · View at Scopus
  198. D. Safronetz, M. Zivcec, R. LaCasse et al., “Pathogenesis and host response in syrian hamsters following intranasal infection with Andes virus,” PLoS Pathogens, vol. 7, no. 12, Article ID e1002426, 2011. View at Publisher · View at Google Scholar · View at Scopus
  199. V. Wahl-Jensen, J. Chapman, L. Asher et al., “Temporal analysis of Andes virus and Sin Nombre virus infections of Syrian hamsters,” Journal of Virology, vol. 81, no. 14, pp. 7449–7462, 2007. View at Publisher · View at Google Scholar · View at Scopus
  200. D. Safronetz, J. Prescott, E. Haddock, D. P. Scott, H. Feldmann, and H. Ebihara, “Hamster-adapted Sin Nombre virus causes disseminated infection and efficiently replicates in pulmonary endothelial cells without signs of disease,” Journal of Virology, vol. 87, no. 8, pp. 4778–4782, 2013. View at Publisher · View at Google Scholar · View at Scopus
  201. R. L. Brocato, C. D. Hammerbeck, T. M. Bell, J. B. Wells, L. A. Queen, and J. W. Hooper, “A lethal disease model for hantavirus pulmonary syndrome in immunosuppressed Syrian hamsters infected with sin nombre virus,” Journal of Virology, vol. 88, no. 2, pp. 811–819, 2014. View at Publisher · View at Google Scholar · View at Scopus
  202. D. Safronetz, J. Prescott, F. Feldmann et al., “Pathophysiology of hantavirus pulmonary syndrome in rhesus macaques,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 19, pp. 7114–7119, 2014. View at Publisher · View at Google Scholar · View at Scopus
  203. J. Botten, K. Mirowsky, D. Kusewitt et al., “Experimental infection model for sin nombre hantavirus in the deer mouse (Peromyscus maniculatus),” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 19, pp. 10578–10583, 2000. View at Publisher · View at Google Scholar · View at Scopus
  204. T. Schountz, M. Acuña-Retamar, S. Feinstein et al., “Kinetics of immune responses in deer mice experimentally infected with sin Nombre virus,” Journal of Virology, vol. 86, no. 18, pp. 10015–10027, 2012. View at Publisher · View at Google Scholar · View at Scopus
  205. M. L. Milazzo, E. J. Eyzaguirre, C. P. Molina, and C. F. Fulhorst, “Maporal viral infection in the syrian golden hamster: a model of hantavirus pulmonary syndrome,” The Journal of Infectious Diseases, vol. 186, no. 10, pp. 1390–1395, 2002. View at Publisher · View at Google Scholar · View at Scopus
  206. R. Yanagihara, H. L. Amyx, P.-W. Lee, D. M. Asher, C. J. Gibbs Jr., and D. C. Gajdusek, “Experimental hantavirus infection in nonhuman primates,” Archives of Virology, vol. 101, no. 1-2, pp. 125–130, 1988. View at Publisher · View at Google Scholar · View at Scopus
  207. R. Yanagihara, A. Svedmyr, H. L. Amyx et al., “Isolation and propagation of nephropathia epidemica virus in bank voles,” Scandinavian Journal of Infectious Diseases, vol. 16, no. 3, pp. 225–228, 1984. View at Publisher · View at Google Scholar · View at Scopus
  208. E. A. Tkachenko, V. N. Bashkirtsev, G. van der Groen, T. K. Dzagurova, A. P. Ivanov, and E. V. Ryltseva, “Isolation in Vero-E6 cells of Hanta virus from Clethrionomys glareolus captured in the Bashkiria area of the U.S.S.R.,” Annales de la Societe Belge de Medecine Tropicale, vol. 64, no. 4, pp. 425–426, 1984. View at Google Scholar · View at Scopus
  209. T. Avsic-Zupanc, S. Y. Xiao, R. Stojanovic, A. Gligic, G. van der Groen, and J. W. LeDuc, “Characterization of Dobrava virus: a Hantavirus from Slovenia, Yugoslavia,” Journal of Medical Virology, vol. 38, no. 2, pp. 132–137, 1992. View at Publisher · View at Google Scholar · View at Scopus
  210. H. W. Lee, L. J. Baek, and K. M. Johnson, “Isolation of Hantaan virus, the etiologic agent of Korean hemorrhagic fever, from wild urban rats,” The Journal of Infectious Diseases, vol. 146, no. 5, pp. 638–644, 1982. View at Publisher · View at Google Scholar · View at Scopus
  211. T. Kitamura, C. Morita, T. Komatsu et al., “Isolation of virus causing hemorrhagic fever with renal syndrome (HFRS) through a cell culture system,” Japanese Journal of Medical Science and Biology, vol. 36, no. 1, pp. 17–25, 1983. View at Publisher · View at Google Scholar · View at Scopus
  212. J. Toro, J. D. Vega, A. S. Khan et al., “An outbreak of hantavirus pulmonary syndrome, Chile, 1997,” Emerging Infectious Diseases, vol. 4, no. 4, pp. 687–694, 1998. View at Publisher · View at Google Scholar · View at Scopus
  213. A. L. Schmaljohn, D. Li, D. L. Negley et al., “Isolation and initial characterization of a newfound hantavirus from California,” Virology, vol. 206, no. 2, pp. 963–972, 1995. View at Publisher · View at Google Scholar · View at Scopus
  214. P. W. Lee, H. L. Amyx, R. Yanagihara, D. C. Gajdusek, D. Goldgaber, and C. J. Gibbs Jr., “Partial characterization of Prospect Hill virus isolated from meadow voles in the United States,” Journal of Infectious Diseases, vol. 152, no. 4, pp. 826–829, 1985. View at Publisher · View at Google Scholar · View at Scopus
  215. D. Wichmann, H.-J. Gröne, M. Frese et al., “Hantaan virus infection causes an acute neurological disease that is fatal in adult laboratory mice,” Journal of Virology, vol. 76, no. 17, pp. 8890–8899, 2002. View at Publisher · View at Google Scholar · View at Scopus
  216. K. Araki, K. Yoshimatsu, B. H. Lee, H. Kariwa, I. Takashima, and J. Arikawa, “Hantavirus-specific CD8(+)-T-cell responses in newborn mice persistently infected with Hantaan virus,” Journal of Virology, vol. 77, no. 15, pp. 8408–8417, 2003. View at Publisher · View at Google Scholar · View at Scopus
  217. M. Taruishi, K. Yoshimatsu, K. Araki et al., “Analysis of the immune response of Hantaan virus nucleocapsid protein-specific CD8+ T cells in mice,” Virology, vol. 365, no. 2, pp. 292–301, 2007. View at Publisher · View at Google Scholar · View at Scopus
  218. Y. C. Yoo, K. Yoshimatsu, Y. Koike et al., “Adjuvant activity of muramyl dipeptide derivatives to enhance immunogenicity of a hantavirus-inactivated vaccine,” Vaccine, vol. 16, no. 2-3, pp. 216–224, 1998. View at Publisher · View at Google Scholar · View at Scopus
  219. I. S. Ha, Y. Choi, Y. S. Park et al., “Development of monoclonal antibodies against Hantaan virus nucleocapsid protein,” Clinical and Diagnostic Laboratory Immunology, vol. 2, no. 4, pp. 439–442, 1995. View at Google Scholar · View at Scopus
  220. M. Bharadwaj, C. R. Lyons, I. A. Wortman, and B. Hjelle, “Intramuscular inoculation of Sin Nombre hantavirus cDNAs induces cellular and humoral immune responses in BALB/c mice,” Vaccine, vol. 17, no. 22, pp. 2836–2843, 1999. View at Publisher · View at Google Scholar · View at Scopus
  221. D. Koletzki, R. Schirmbeck, Å. Lundkvist, H. Meisel, D. H. Krüger, and R. Ulrich, “DNA vaccination of mice with a plasmid encoding Puumala hantavirus nucleocapsid protein mimics the B-cell response induced by virus infection,” Journal of Biotechnology, vol. 84, no. 1, pp. 73–78, 2000. View at Publisher · View at Google Scholar · View at Scopus
  222. G. Bucht, K. B. Sjölander, S. Eriksson, L. Lindgren, Å. Lundkvist, and F. Elgh, “Modifying the cellular transport of DNA-based vaccines alters the immune response to hantavirus nucleocapsid protein,” Vaccine, vol. 19, no. 28-29, pp. 3820–3829, 2001. View at Publisher · View at Google Scholar · View at Scopus
  223. Z. Xu, L. Wei, L. Wang, H. Wang, and S. Jiang, “The in vitro and in vivo protective activity of monoclonal antibodies directed against Hantaan virus: potential application for immunotherapy and passive immunization,” Biochemical and Biophysical Research Communications, vol. 298, no. 4, pp. 552–558, 2002. View at Publisher · View at Google Scholar · View at Scopus
  224. P. Johansson, T. Lindgren, M. Lundström, A. Holmström, F. Elgh, and G. Bucht, “PCR-generated linear DNA fragments utilized as a hantavirus DNA vaccine,” Vaccine, vol. 20, no. 27-28, pp. 3379–3388, 2002. View at Publisher · View at Google Scholar · View at Scopus
  225. Y. Choi, C.-J. Ahn, K.-M. Seong, M.-Y. Jung, and B.-Y. Ahn, “Inactivated Hantaan virus vaccine derived from suspension culture of Vero cells,” Vaccine, vol. 21, no. 17-18, pp. 1867–1873, 2003. View at Publisher · View at Google Scholar · View at Scopus
  226. A. Gedvilaite, A. Zvirbliene, J. Staniulis, K. Sasnauskas, D. H. Krüger, and R. Ulrich, “Segments of puumala hantavirus nucleocapsid protein inserted into chimeric polyomavirus-derived virus-like particles induce a strong immune response in mice,” Viral Immunology, vol. 17, no. 1, pp. 51–68, 2004. View at Publisher · View at Google Scholar · View at Scopus
  227. A. Geldmacher, M. Schmaler, D. H. Krüger, and R. Ulrich, “Yeast-expressed hantavirus Dobrava nucleocapsid protein induces a strong, long-lasting, and highly cross-reactive immune response in mice,” Viral Immunology, vol. 17, no. 1, pp. 115–122, 2004. View at Publisher · View at Google Scholar · View at Scopus
  228. L. Y. Zheng, L. Mou, S. Lin, R. M. Lu, and E. J. Luo, “Enhancing DNA vaccine potency against hantavirus by co-administration of interleukin-12 expression vector as a genetic adjuvant,” Chinese Medical Journal, vol. 118, no. 4, pp. 313–319, 2005. View at Google Scholar · View at Scopus
  229. A. Geldmacher, D. Skrastina, G. Borisova et al., “A hantavirus nucleocapsid protein segment exposed on hepatitis B virus core particles is highly immunogenic in mice when applied without adjuvants or in the presence of pre-existing anti-core antibodies,” Vaccine, vol. 23, no. 30, pp. 3973–3983, 2005. View at Publisher · View at Google Scholar · View at Scopus
  230. G.-J. Woo, E.-Y. Chun, H. K. Keun, and W. Kim, “Analysis of immune responses against nucleocapsid protein of the Hantaan virus elicited by virus infection or DNA vaccination,” Journal of Microbiology, vol. 43, no. 6, pp. 537–545, 2005. View at Google Scholar · View at Scopus
  231. B.-H. Lee, K. Yoshimatsu, K. Araki, M. Okumura, I. Nakamura, and J. Arikawa, “A pseudotype vesicular stomatitis virus containing Hantaan virus envelope glycoproteins G1 and G2 as an alternative to hantavirus vaccine in mice,” Vaccine, vol. 24, no. 15, pp. 2928–2934, 2006. View at Publisher · View at Google Scholar · View at Scopus
  232. M. Lindkvist, K. Lahti, B. Lilliehöök, A. Holmström, C. Ahlm, and G. Bucht, “Cross-reactive immune responses in mice after genetic vaccination with cDNA encoding hantavirus nucleocapsid proteins,” Vaccine, vol. 25, no. 9, pp. 1690–1699, 2007. View at Publisher · View at Google Scholar · View at Scopus
  233. Y. Xiong, Y. Yuan, M. Jia, B. Yu, and H. Huang, “Stable expression of Hantavirus H8205 strain G1/IL-2 gene and immune protection of the fusion gene,” Journal of Huazhong University of Science and Technology. Medical Sciences, vol. 27, no. 2, pp. 124–127, 2007. View at Publisher · View at Google Scholar · View at Scopus
  234. H. Hao, L. Xiu, Z. Zehua et al., “Genetic immunization with Hantavirus vaccine combining expression of G2 glycoprotein and fused interleukin-2,” Genetic Vaccines and Therapy, vol. 6, article 15, 2008. View at Publisher · View at Google Scholar · View at Scopus
  235. D. Safronetz, N. R. Hegde, H. Ebihara et al., “Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with Andes virus,” Journal of Virology, vol. 83, no. 14, pp. 7285–7295, 2009. View at Publisher · View at Google Scholar · View at Scopus
  236. C. Zhao, Y. Sun, Y. Zhao et al., “Immunogenicity of a multi-epitope DNA vaccine against hantavirus,” Human Vaccines & Immunotherapeutics, vol. 8, no. 2, pp. 208–215, 2012. View at Publisher · View at Google Scholar · View at Scopus
  237. J. Klingström, I. Maljkovic, B. Zuber, E. Rollman, A. Kjerrström, and Å. Lundkvist, “Vaccination of C57/BL6 mice with Dobrava hantavirus nucleocapsid protein in Freund's adjuvant induced partial protection against challenge,” Vaccine, vol. 22, no. 29-30, pp. 4029–4034, 2004. View at Publisher · View at Google Scholar · View at Scopus
  238. J. Li, Z. X. Ye, K. N. Li et al., “HSP70 gene fused with Hantavirus S segment DNA significantly enhances the DNA vaccine potency against hantaviral nucleocapsid protein in vivo,” Vaccine, vol. 25, no. 2, pp. 239–252, 2007. View at Publisher · View at Google Scholar · View at Scopus
  239. J. Li, K. N. Li, J. Gao, J. H. Cui, Y. F. Liu, and S. J. Yang, “Heat shock protein 70 fused to or complexed with hantavirus nucleocapsid protein significantly enhances specific humoral and cellular immune responses in C57BL/6 mice,” Vaccine, vol. 26, no. 25, pp. 3175–3187, 2008. View at Publisher · View at Google Scholar · View at Scopus
  240. S. Cao, Y. Zhang, F. Liu et al., “Secretory expression and purification of recombinant escherichia coli heat-Labile enterotoxin B subunit and its applications on intranasal vaccination of hantavirus,” Molecular Biotechnology, vol. 41, no. 2, pp. 91–98, 2009. View at Publisher · View at Google Scholar · View at Scopus
  241. C. Li, F. Liu, M. Liang et al., “Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice,” Vaccine, vol. 28, no. 26, pp. 4294–4300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  242. P.-Y. Li, L. Yu, X.-A. Wu et al., “Modification of the adenoviral transfer vector enhances expression of the Hantavirus fusion protein GnS0.7 and induces a strong immune response in C57BL/6 mice,” Journal of Virological Methods, vol. 179, no. 1, pp. 90–96, 2012. View at Publisher · View at Google Scholar · View at Scopus
  243. F. Liu, M. Liang, S. Cao et al., “Fusion with extracellular domain of cytotoxic T-lymphocyte-associated-antigen 4 leads to enhancement of immunogenicity of Hantaan virus DNA vaccines in C57BL/6 mice,” Virology Journal, vol. 8, article 448, 2011. View at Publisher · View at Google Scholar · View at Scopus
  244. K. Li, P.-Y. Li, X.-A. Wu et al., “Induction of Hantaan virus-specific immune responses in C57BL/6 mice by immunization with a modified recombinant adenovirus containing the chimeric gene, GcS0.7,” International Journal of Molecular Medicine, vol. 32, no. 3, pp. 709–716, 2013. View at Publisher · View at Google Scholar · View at Scopus
  245. L. Cheng, L. Yu, X. Wu et al., “Induction of specific humoral and cellular immune responses in a mouse model following gene fusion of HSP70C and Hantaan virus Gn and S0.7 in an adenoviral vector,” PLoS ONE, vol. 9, no. 2, Article ID e88183, 2014. View at Publisher · View at Google Scholar · View at Scopus
  246. L. Yu, W. Bai, X. Wu et al., “A recombinant pseudotyped lentivirus expressing the envelope glycoprotein of hantaan virus induced protective immunity in mice,” Virology Journal, vol. 10, article 301, 2013. View at Publisher · View at Google Scholar · View at Scopus
  247. P. Maes, J. Clement, B. Cauwe et al., “Truncated recombinant Puumala virus nucleocapsid proteins protect mice against challenge in vivo,” Viral Immunology, vol. 21, no. 1, pp. 49–60, 2008. View at Publisher · View at Google Scholar · View at Scopus
  248. P. Maes, E. Keyaerts, V. Bonnet et al., “Truncated recombinant dobrava hantavirus nucleocapsid proteins induce strong, long-lasting immune responses in mice,” Intervirology, vol. 49, no. 5, pp. 253–260, 2006. View at Publisher · View at Google Scholar · View at Scopus
  249. K. Maeda, K. West, D. Hayasaka, F. A. Ennis, and M. Terajima, “Recombinant adenovirus vector vaccine induces stronger cytotoxic T-cell responses than recombinant vaccinia virus vector, plasmid DNA, or a combination of these,” Viral Immunology, vol. 18, no. 4, pp. 657–667, 2005. View at Publisher · View at Google Scholar · View at Scopus
  250. M. Bharadwaj, K. Mirowsky, C. Ye et al., “Genetic vaccines protect against Sin Nombre hantavirus challenge in the deer mouse (Peromyscus maniculatus),” The Journal of General Virology, vol. 83, no. 7, pp. 1745–1751, 2002. View at Google Scholar · View at Scopus
  251. A. A. Rizvanov, A. G. M. van Geelen, S. Morzunov et al., “Generation of a recombinant cytomegalovirus for expression of a hantavirus glycoprotein,” Journal of Virology, vol. 77, no. 22, pp. 12203–12210, 2003. View at Publisher · View at Google Scholar · View at Scopus
  252. K. Yoshimatsu, J. Arikawa, S. Ohbora, and C. Itakura, “Hantavirus Infection in SCID Mice,” The Journal of Veterinary Medical Science, vol. 59, no. 10, pp. 863–868, 1997. View at Publisher · View at Google Scholar · View at Scopus
  253. T. Koma, K. Yoshimatsu, N. Nagata et al., “Neutrophil depletion suppresses pulmonary vascular hyperpermeability and occurrence of pulmonary edema caused by hantavirus infection in C.B-17 SCID mice,” Journal of Virology, vol. 88, no. 13, pp. 7178–7188, 2014. View at Publisher · View at Google Scholar · View at Scopus
  254. K. Araki, K. Yoshimatsu, B.-H. Lee et al., “Age-dependent hantavirus-specific CD8+ T-cell responses in mice infected with Hantaan virus,” Archives of Virology, vol. 149, no. 7, pp. 1373–1382, 2004. View at Google Scholar · View at Scopus
  255. T. Sanada, H. Kariwa, N. Nagata et al., “Puumala virus infection in Syrian hamsters (Mesocricetus auratus) resembling hantavirus infection in natural rodent hosts,” Virus Research, vol. 160, no. 1-2, pp. 108–119, 2011. View at Publisher · View at Google Scholar · View at Scopus
  256. K. I. Kamrud, J. W. Hooper, F. Elgh, and C. S. Schmaljohn, “Comparison of the protective efficacy of naked DNA, DNA-based sindbis replicon, and packaged sindbis replicon vectors expressing Hantavirus structural genes in hamsters,” Virology, vol. 263, no. 1, pp. 209–219, 1999. View at Publisher · View at Google Scholar · View at Scopus
  257. M. Liang, Y.-K. Chu, and C. Schmaljohn, “Bacterial expression of neutralizing mouse monoclonal antibody Fab fragments to Hantaan virus,” Virology, vol. 217, no. 1, pp. 262–271, 1996. View at Publisher · View at Google Scholar · View at Scopus
  258. K. Hardcastle, D. Scott, D. Safronetz et al., “Laguna Negra virus infection causes Hantavirus pulmonary syndrome in Turkish hamsters (Mesocricetus brandti),” Veterinary Pathology, 2015. View at Publisher · View at Google Scholar
  259. C. D. Hammerbeck and J. W. Hooper, “T Cells are not required for pathogenesis in the Syrian hamster model of hantavirus pulmonary syndrome,” Journal of Virology, vol. 85, no. 19, pp. 9929–9944, 2011. View at Publisher · View at Google Scholar · View at Scopus
  260. K. S. Brown, D. Safronetz, A. Marzi, H. Ebihara, and H. Feldmann, “Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with andes virus,” Journal of Virology, vol. 85, no. 23, pp. 12781–12791, 2011. View at Publisher · View at Google Scholar · View at Scopus
  261. J. Prescott, B. L. DeBuysscher, K. S. Brown, and H. Feldmann, “Long-term single-dose efficacy of a vesicular Stomatitis virus-based Andes virus vaccine in Syrian hamsters,” Viruses, vol. 6, no. 2, pp. 516–523, 2014. View at Publisher · View at Google Scholar · View at Scopus
  262. D. M. Custer, E. Thompson, C. S. Schmaljohn, T. G. Ksiazek, and J. W. Hooper, “Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine,” Journal of Virology, vol. 77, no. 18, pp. 9894–9905, 2003. View at Publisher · View at Google Scholar · View at Scopus
  263. K. W. Spik, C. Badger, I. Mathiessen, T. Tjelle, J. W. Hooper, and C. Schmaljohn, “Mixing of M segment DNA vaccines to Hantaan virus and Puumala virus reduces their immunogenicity in hamsters,” Vaccine, vol. 26, no. 40, pp. 5177–5181, 2008. View at Publisher · View at Google Scholar · View at Scopus
  264. R. L. Brocato, M. J. Josleyn, V. Wahl-Jensen, C. S. Schmaljohn, and J. W. Hooper, “Construction and nonclinical testing of a Puumala virus synthetic M gene-based DNA vaccine,” Clinical and Vaccine Immunology, vol. 20, no. 2, pp. 218–226, 2013. View at Publisher · View at Google Scholar · View at Scopus
  265. R. Brocato, M. Josleyn, J. Ballantyne, P. Vial, and J. W. Hooper, “DNA vaccine-generated duck polyclonal antibodies as a postexposure prophylactic to prevent hantavirus pulmonary syndrome (HPS),” PLoS ONE, vol. 7, no. 4, Article ID e35996, 2012. View at Publisher · View at Google Scholar · View at Scopus
  266. J. W. Hooper, R. L. Brocato, S. A. Kwilas et al., “DNA vaccine-derived human IgG produced in transchromosomal bovines protect in lethal models of hantavirus pulmonary syndrome,” Science Translational Medicine, vol. 6, no. 264, Article ID 264ra162, 2014. View at Publisher · View at Google Scholar · View at Scopus
  267. J. W. Hooper, D. M. Custer, J. Smith, and V. Wahl-Jensen, “Hantaan/Andes virus DNA vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates,” Virology, vol. 347, no. 1, pp. 208–216, 2006. View at Publisher · View at Google Scholar · View at Scopus
  268. P. A. Vial, F. Valdivieso, M. Calvo et al., “A non-randomized multicentre trial of human immune plasma for treatment of hantavirus cardiopulmonary syndrome by ANDV,” Antiviral Therapy, 2014. View at Publisher · View at Google Scholar
  269. C. B. Jonsson, J. Hooper, and G. Mertz, “Treatment of hantavirus pulmonary syndrome,” Antiviral Research, vol. 78, no. 1, pp. 162–169, 2008. View at Publisher · View at Google Scholar · View at Scopus
  270. R. C. McDermid, R. T. N. Gibney, R. J. Brisebois, and N. M. Skjodt, “Drotrecogin alpha (activated) in two patients with the hantavirus cardiopulmonary syndrome,” Canadian Respiratory Journal, vol. 13, no. 5, pp. 272–274, 2006. View at Google Scholar · View at Scopus
  271. M. Ogg, C. B. Jonsson, J. V. Camp, and J. W. Hooper, “Ribavirin protects Syrian hamsters against lethal hantavirus pulmonary syndrome—after intranasal exposure to andes virus,” Viruses, vol. 5, no. 11, pp. 2704–2720, 2013. View at Publisher · View at Google Scholar · View at Scopus
  272. D. Safronetz, D. Falzarano, D. P. Scott, Y. Furuta, H. Feldmann, and B. B. Gowen, “Antiviral efficacy of favipiravir against two prominent etiological agents of hantavirus pulmonary syndrome,” Antimicrobial Agents and Chemotherapy, vol. 57, no. 10, pp. 4673–4680, 2013. View at Publisher · View at Google Scholar · View at Scopus
  273. D. Safronetz, E. Haddock, F. Feldmann, H. Ebihara, and H. Feldmann, “In vitro and in vivo activity of Ribavirin against Andes virus infection,” PLoS ONE, vol. 6, no. 8, Article ID e23560, 2011. View at Publisher · View at Google Scholar · View at Scopus
  274. J. Prescott, D. Safronetz, E. Haddock, S. Robertson, D. Scott, and H. Feldmann, “The adaptive immune response does not influence hantavirus disease or persistence in the syrian hamster,” Immunology, vol. 140, no. 2, pp. 168–178, 2013. View at Publisher · View at Google Scholar · View at Scopus
  275. L. B. Chen and W. S. Yang, “Abnormalities of T cell immunoregulation in hemorrhagic fever with renal syndrome,” The Journal of Infectious Diseases, vol. 161, no. 5, pp. 1016–1019, 1990. View at Publisher · View at Google Scholar · View at Scopus
  276. S. Gupta, M. Braun, N. D. Tischler et al., “Hantavirus-infection confers resistance to cytotoxic lymphocyte-mediated apoptosis,” PLoS Pathogens, vol. 9, no. 3, Article ID e1003272, 2013. View at Publisher · View at Google Scholar · View at Scopus
  277. N. Tchitchek, D. Safronetz, A. L. Rasmussen et al., “Sequencing, annotation and analysis of the Syrian hamster (Mesocricetus auratus) transcriptome,” PLoS ONE, vol. 9, no. 11, Article ID e112617, 2014. View at Publisher · View at Google Scholar · View at Scopus
  278. J. Klingström, P. Heyman, S. Escutenaire et al., “Rodent host specificity of european hantaviruses: evidence of Puumala virus interspecific spillover,” Journal of Medical Virology, vol. 68, no. 4, pp. 581–588, 2002. View at Publisher · View at Google Scholar · View at Scopus
  279. W.-P. Guo, X.-D. Lin, W. Wang et al., “Phylogeny and origins of hantaviruses harbored by bats, insectivores, and rodents,” PLoS Pathogens, vol. 9, no. 2, Article ID e1003159, 2013. View at Publisher · View at Google Scholar · View at Scopus
  280. C. H. Calisher, J. E. Childs, H. E. Field, K. V. Holmes, and T. Schountz, “Bats: important reservoir hosts of emerging viruses,” Clinical Microbiology Reviews, vol. 19, no. 3, pp. 531–545, 2006. View at Publisher · View at Google Scholar · View at Scopus
  281. J. Botten, K. Mirowsky, D. Kusewitt et al., “Persistent Sin Nombre virus infection in the deer mouse (Peromyscus maniculatus) model: sites of replication and strand-specific expression,” Journal of Virology, vol. 77, no. 2, pp. 1540–1550, 2003. View at Publisher · View at Google Scholar · View at Scopus
  282. T. Schountz, S. Quackenbush, J. Rovnak et al., “Differential lymphocyte and antibody responses in deer mice infected with Sin Nombre hantavirus or Andes hantavirus,” Journal of Virology, vol. 88, no. 15, pp. 8319–8331, 2014. View at Publisher · View at Google Scholar · View at Scopus
  283. J. R. Spengler, E. Haddock, D. Gardner, B. Hjelle, H. Feldmann, and J. Prescott, “Experimental Andes virus infection in deer mice: characteristics of infection and clearance in a heterologous rodent host,” PLoS ONE, vol. 8, no. 1, Article ID e55310, 2013. View at Publisher · View at Google Scholar · View at Scopus
  284. H. Kariwa, M. Kimura, S. Yoshizumi et al., “Modes of Seoul virus infections: persistency in newborn rats and transiency in adult rats,” Archives of Virology, vol. 141, no. 12, pp. 2327–2338, 1996. View at Publisher · View at Google Scholar · View at Scopus
  285. J. D. Easterbrook and S. L. Klein, “Seoul virus enhances regulatory and reduces proinflammatory responses in male Norway rats,” Journal of Medical Virology, vol. 80, no. 7, pp. 1308–1318, 2008. View at Publisher · View at Google Scholar · View at Scopus
  286. M. F. Hannah, V. B. Bajic, and S. L. Klein, “Sex differences in the recognition of and innate antiviral responses to Seoul virus in Norway rats,” Brain, Behavior, and Immunity, vol. 22, no. 4, pp. 503–516, 2008. View at Publisher · View at Google Scholar · View at Scopus
  287. S. L. Klein, A. Cernetich, S. Hilmer, E. P. Hoffman, A. L. Scott, and G. E. Glass, “Differential expression of immunoregulatory genes in male and female Norway rats following infection with Seoul virus,” Journal of Medical Virology, vol. 74, no. 1, pp. 180–190, 2004. View at Publisher · View at Google Scholar · View at Scopus
  288. T. Schountz and J. Prescott, “Hantavirus immunology of rodent reservoirs: current status and future directions,” Viruses, vol. 6, no. 3, pp. 1317–1335, 2014. View at Publisher · View at Google Scholar · View at Scopus
  289. A. K. McElroy, M. Bray, D. S. Reed, and C. S. Schmaljohn, “Andes virus infection of cynomolgus macaques,” The Journal of Infectious Diseases, vol. 186, no. 12, pp. 1706–1712, 2002. View at Publisher · View at Google Scholar · View at Scopus
  290. J. Klingström, A. Plyusnin, A. Vaheri, and Å. Lundkvist, “Wild-type Puumala hantavirus infection induces cytokines, C-reactive protein, creatinine, and nitric oxide in cynomolgus macaques,” Journal of Virology, vol. 76, no. 1, pp. 444–449, 2002. View at Publisher · View at Google Scholar · View at Scopus
  291. T. Sironen, J. Klingström, A. Vaheri, L. C. Andersson, Å. Lundkvist, and A. Plyusnin, “Pathology of Puumala hantavirus infection in Macaques,” PLoS ONE, vol. 3, no. 8, Article ID e3035, 2008. View at Publisher · View at Google Scholar · View at Scopus
  292. J. Klingström, K. I. Falk, and Å. Lundkvist, “Delayed viremia and antibody responses in Puumala hantavirus challenged passively immunized cynomolgus macaques,” Archives of Virology, vol. 150, no. 1, pp. 79–92, 2005. View at Publisher · View at Google Scholar · View at Scopus
  293. J. Klingström, M. Stoltz, J. Hardestam, C. Ahlm, and Å. Lundkvist, “Passive immunization protects cynomolgus macaques against Puumala hantavirus challenge,” Antiviral Therapy, vol. 13, no. 1, pp. 125–133, 2008. View at Google Scholar · View at Scopus
  294. M. G. Kortepeter, T. J. Cieslak, and E. M. Eitzen, “Bioterrorism,” Journal of Environmental Health, vol. 63, no. 6, pp. 21–24, 2001. View at Google Scholar · View at Scopus
  295. S. R. Samoilovich, G. Carballal, and M. C. Weissenbacher, “Protection against a pathogenic strain of Junin virus by mucosal infection with an attenuated strain,” The American Journal of Tropical Medicine and Hygiene, vol. 32, no. 4, pp. 825–828, 1983. View at Google Scholar · View at Scopus
  296. J. R. Oubina and G. Carballal, “Neurotropism of a high-passage XJ strain of Junin virus,” Journal of Medical Virology, vol. 15, no. 2, pp. 157–161, 1985. View at Publisher · View at Google Scholar · View at Scopus
  297. É. Bergeron, A. K. Chakrabarti, B. H. Bird et al., “Reverse genetics recovery of Lujo virus and role of virus RNA secondary structures in efficient virus growth,” Journal of Virology, vol. 86, no. 19, pp. 10759–10765, 2012. View at Publisher · View at Google Scholar · View at Scopus
  298. P. J. Snoy, “Establishing efficacy of human products using animals: the US food and drug administration's ‘animal rulea’,” Veterinary Pathology, vol. 47, no. 5, pp. 774–778, 2010. View at Publisher · View at Google Scholar · View at Scopus
  299. R. Mercado, “Rodent control programmes in areas affected by Bolivian haemorrhagic fever,” Bulletin of the World Health Organization, vol. 52, no. 4-5, pp. 691–696, 1975. View at Google Scholar · View at Scopus
  300. R. A. Keenlyside, J. B. McCormick, P. A. Webb, E. Smith, L. Elliott, and K. M. Johnson, “Case-control study of Mastomys natalensis and humans in Lassa virus-infected households in Sierra Leone,” The American Journal of Tropical Medicine and Hygiene, vol. 32, no. 4, pp. 829–837, 1983. View at Google Scholar · View at Scopus
  301. M. Mateo, C. Carbonnelle, O. Reynard et al., “VP24 is a molecular determinant of Ebola virus virulence in guinea pigs,” The Journal of Infectious Diseases, vol. 204, supplement 3, pp. S1011–S1020, 2011. View at Publisher · View at Google Scholar · View at Scopus
  302. J. J. Núñez, C. L. Fritz, B. Knust et al., “Hantavirus infections among overnight visitors to Yosemite National Park, California, USA, 2012,” Emerging Infectious Diseases, vol. 20, no. 3, pp. 386–393, 2014. View at Publisher · View at Google Scholar · View at Scopus